Search Results - "Vcelar, B."

Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques by Moog, C, Dereuddre-Bosquet, N, Teillaud, J-L, Biedma, M E, Holl, V, Van Ham, G, Heyndrickx, L, Van Dorsselaer, A, Katinger, D, Vcelar, B, Zolla-Pazner, S, Mangeot, I, Kelly, C, Shattock, R J, Le Grand, R

“…Definition of antibody (Ab) functions capable of preventing mucosal HIV transmission may be critical to both effective vaccine development and the prophylactic…”
Get full text

PP119—Effect of liposomal curcumin on red blood cells in vitro by Storka, A, Vcelar, B, Helson, L, Wolzt, M

Get full text

Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates by Moog, C, Dereuddre-Bosquet, N, Biedma, M, Schmidt, S, Decoville, T, Mangeot, I, Zolla-Pazner, S, Vcelar, B, Katinger, D, Holl, V, Le Grand, R

“…Doc number: O38…”
Get full text

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies by Trkola, Alexandra, Günthard, Huldrych F, Kuster, Herbert, Rusert, Peter, Joos, Beda, Fischer, Marek, Leemann, Christine, Manrique, Amapola, Huber, Michael, Rehr, Manuela, Oxenius, Annette, Weber, Rainer, Stiegler, Gabriela, Vcelar, Brigitta, Katinger, Hermann, Aceto, Leonardo

“…To determine the protective potential of the humoral immune response against HIV-1 in vivo we evaluated the potency of three neutralizing antibodies (2G12, 2F5…”
Get full text

Elimination of ornithogalum mosaic virus in the Ornithogalum cv. Rogel through meristem tip culture and chemotherapy by VCELAR, B. M, FERREIRA, D. I, NIEDERWIESER, J. G

Get full text

Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data by VCELAR, Brigitta, STIEGLER, Gabriela, KATINGER, Hermann, WOLF, Hermann M, MUNTEAN, Wolfgang, LESCHNIK, Bettina, MEHANDRU, Saurabh, MARKOWITZ, Martin, ARMBRUSTER, Christine, KUNERT, Renate, EIBL, Martha M

“…The broadly neutralizing recombinant human HIV-1 antibodies 4E10, 2F5 and Igh1b12 are reported to have autoreactive potential, which is significant for HIV-1…”
Get full text

Long-Term Multiple-Dose Pharmacokinetics of Human Monoclonal Antibodies (MAbs) against Human Immunodeficiency Virus Type 1 Envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5) by JOOS, Beda, TRKOLA, Alexandra, KUSTER, Herbert, ACETO, Leonardo, FISCHER, Marek, STIEGLER, Gabriela, ARMBRUSTER, Christine, VCELAR, Brigitta, KATINGER, Hermann, GÜNTHARD, Huldrych F

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Neutralization Profiles of Newly Transmitted Human Immunodeficiency Virus Type 1 by Monoclonal Antibodies 2G12, 2F5, and 4E10 by MEHANDRU, Saurabh, WRIN, Terri, MARKOWITZ, Martin, GALOVICH, Justin, STIEGLER, Gabriela, VCELAR, Brigitta, HURLEY, Arlene, HOGAN, Christine, VASAN, Sandhya, KATINGER, Hermann, PETROPOULOS, Christos J

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation by STIEGLER, Gabriela, ARMBRUSTER, Christine, VETTER, Norbert, KATINGER, Hermann, VCELAR, Brigitta, STOIBER, Heribert, KUNERT, Renate, MICHAEL, Nelson L, JAGODZINSKI, Linda L, AMMANN, Christoph, JÄGER, Walter, JACOBSON, Jeffrey

“…The human monoclonal antibodies (MAbs) 2F5 and 2G12 were identified to be two of the most potent neutralizing antibodies against HIV-1. In a first human study…”
Get full text

Liposomal Recombinant Human Superoxide Dismutase for the Treatment of Peyronie's Disease: A Randomized Placebo-Controlled Double-Blind Prospective Clinical Study by Riedl, Claus R., Sternig, Peter, Gallé, Günter, Langmann, Florian, Vcelar, Brigitta, Vorauer, Karola, Wagner, Andreas, Katinger, Hermann, Pflüger, Heinz

“…To demonstrate the efficacy and safety of a topical gel containing liposomally encapsulated recombinant human Superoxide Dismutase (lrhSOD) in the treatment of…”
Get full text

Live cold-adapted influenza A vaccine produced in Vero cell line by Romanova, Julia, Katinger, Dietmar, Ferko, Boris, Vcelar, Brigitta, Sereinig, Sabine, Kuznetsov, Oleg, Stukova, Marina, Erofeeva, Marjana, Kiselev, Oleg, Katinger, Hermann, Egorov, Andrej

“…The African green monkey kidney (Vero) cell line was used as a substrate for the development of a live cold-adapted (ca) reassortant influenza vaccine. For…”
Get full text

Pilot study on liposomal recombinant human superoxide dismutase for the treatment of Peyronie's disease by Riedl, C R, Plas, E, Vorauer, K, Vcelar, B, Wagner, A, Pflüger, H

“…To assess the efficacy and safety of liposomally encapsulated recombinant human superoxide dismutase (lrhSOD) for the treatment of Peyronie's disease. In an…”
Get more information

Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12 by Armbruster, Christine, Stiegler, Gabriela M., Vcelar, Brigitta A., Jäger, Walter, Köller, Ursula, Jilch, Ruth, Ammann, Christoph G., Pruenster, Monika, Stoiber, Heribert, Katinger, Hermann W. D.

“…Objectives: To study the safety, immunogenicity and pharmacokinetics of the human monoclonal antibody (hMAb) 4E10 alone and in combination with the hMAbs 2F5…”
Get full text

A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1 by ARMBRUSTER, Christine, STIEGLER, Gabriela M, VCELAR, Brigitta A, JÄGER, Walter, MICHAEL, Nelson L, VETTER, Norbert, KATINGER, Hermann W. D

“…To study the safety, immunogenicity and pharmacokinetics of two intravenously administered human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1 in…”
Get full text

865Liposomal recombinant human superoxide dismutase for the treatment of peyronie's disease: A randomized placebo-controlled double-blind clinical study by Riedl, C., Steming, P., Langmann, F., Galle, G., Engelhardt, P.F., Vcelar, B., Vorauer, K., Wagner, A., Katinger, H., Pflüger, H.

Get full text